In chronic HBV infections, individuals in the immune-active phase (also called the CHB phase) with active hepatitis typically exhibit ~10-fold higher levels of qAnti-HBc compared to those in the immune-tolerant or inactive-carrier phases when hepatitis is absent [26]. This evidence concerns the gene KRT88P and hepatitis A virus infection.